Global Sacral Nerve Stimulation Market by Types, Applications, and Region — Market Size, Share and Trends, Forecasts 2020–2026

Global Sacral Nerve Stimulation Market was valued at USD 845.4 Million in 2018, growing at CAGR of 13.2% over the forecast period 2020–2026. Increasing demand for minimal invasive therapy, rising number of patients suffering from Overactive Bladder (OAB) and growing prevalence of urinary bladder diseases are key factors driving the market.

Get Sample Report: https://dataintelo.com/request-sample/?reportId=642

The report segments the market on the basis of product, type, application, and region. Based on product, the market is bifurcated into implantable SNS devices and external SNS devices. By type, it is classified into electrical muscle stimulation and transcutaneous electrical nerve stimulation. In terms of application, it is divided into urinary & fecal incontinence, urge incontinence, chronic anal fissure, and others. Geographically, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Market Trends, Drivers, Restraints, and Opportunities:

Failure of traditional therapies for constipation and fecal incontinence are forcing hospitals and clinics to use electrical stimulation devices. This, in turn, is projected to boost the sacral nerve stimulation market in the forthcoming years.
The sacral nerve transmitter is noiseless and invisible to others. This makes it a preferred option for treating children.
The major challenge in the use of the SNS is a lack of knowledge on the occurrence and management of suboptimal therapeutic effects and the complications associated with sacral nerve stimulation for fecal incontinence and constipation.
SNS is effective, shows a substantial improvement in fecal incontinence; thus creating opportunities in the market during the forecast period.